These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22015303)

  • 1. Local therapy for breast cancer in malignant lymphoma survivors.
    Intra M; Mattar D; Sangalli C; Rotmensz N; Viale G; Galimberti V; Luini A; Veronesi P; Colleoni M; Zurrida S; Orecchia R; Veronesi U
    Breast; 2011 Oct; 20 Suppl 3():S99-103. PubMed ID: 22015303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new option for early breast cancer patients previously irradiated for Hodgkin's disease: intraoperative radiotherapy with electrons (ELIOT).
    Intra M; Gentilini O; Veronesi P; Ciocca M; Luini A; Lazzari R; Soteldo J; Farante G; Orecchia R; Veronesi U
    Breast Cancer Res; 2005; 7(5):R828-32. PubMed ID: 16168129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial breast brachytherapy as the primary treatment for breast cancer diagnosed after mantle radiation therapy for Hodgkin's disease.
    Chadha M; Yoon H; Feldman S; Shah N; Moore E; Harrison LB
    Am J Clin Oncol; 2009 Apr; 32(2):132-6. PubMed ID: 19307955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis.
    Fastner G; Sedlmayer F; Merz F; Deutschmann H; Reitsamer R; Menzel C; Stierle C; Farmini A; Fischer T; Ciabattoni A; Mirri A; Hager E; Reinartz G; Lemanski C; Orecchia R; Valentini V
    Radiother Oncol; 2013 Aug; 108(2):279-86. PubMed ID: 23830467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.
    Chadha M; Feldman S; Boolbol S; Wang L; Harrison LB
    Brachytherapy; 2008; 7(1):22-8. PubMed ID: 18299110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Breast conserving surgery in locoregional treatment of breast carcinoma after Hodgkin lymphoma].
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Cancer Radiother; 2012 Apr; 16(2):128-35. PubMed ID: 22341508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons.
    Veronesi U; Orecchia R; Luini A; Galimberti V; Zurrida S; Intra M; Veronesi P; Arnone P; Leonardi MC; Ciocca M; Lazzari R; Caldarella P; Rotmensz N; Sangalli C; Sances D; Maisonneuve P
    Breast Cancer Res Treat; 2010 Nov; 124(1):141-51. PubMed ID: 20711810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast-conserving therapy after previous irradiation for lymphoma.
    Nguyen SK; Dagnault A
    Breast Cancer Res Treat; 2010 Dec; 124(3):845-9. PubMed ID: 19462230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience.
    Mussari S; Sabino Della Sala W; Busana L; Vanoni V; Eccher C; Zani B; Menegotti L; Tomio L
    Strahlenther Onkol; 2006 Oct; 182(10):589-95. PubMed ID: 17013572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative radiation therapy: is it a standard now?
    Orecchia R; Leonardo MC
    Breast; 2011 Oct; 20 Suppl 3():S111-5. PubMed ID: 22015276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology.
    Leonardi MC; Maisonneuve P; Mastropasqua MG; Morra A; Lazzari R; Rotmensz N; Sangalli C; Luini A; Veronesi U; Orecchia R
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):806-13. PubMed ID: 22245196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after breast conservation treatment with radiation in women with prior nonbreast malignancy and subsequent invasive breast carcinoma.
    Nemani D; Vapiwala N; Hwang WT; Solin LJ
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1055-60. PubMed ID: 18929447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial breast irradiation as second conservative treatment for local breast cancer recurrence.
    Hannoun-Levi JM; Houvenaeghel G; Ellis S; Teissier E; Alzieu C; Lallement M; Cowen D
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1385-92. PubMed ID: 15590169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
    Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
    Antonucci JV; Wallace M; Goldstein NS; Kestin L; Chen P; Benitez P; Dekhne N; Martinez A; Vicini F
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):447-52. PubMed ID: 19058921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
    Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
    Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.